Article
Genetic testing today.
Annals of surgical oncology - 1 Oct 2014
Euhus David
Abstract excerpt
BACKGROUND: The commercial introduction of next-generation sequencing has made it possible to test for mutations in all known or suspected breast cancer predisposition genes in one panel, at one time, for about the same cost as a BRCA gene test. Clinicians are increasingly presented with the challenge of advising patients with mutations in rare breast cancer predisposition genes. METHODS: Literature review and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
